Best Researcher Award
Laurence Klotz
University of Toronto
Laurence Klotz the Best Researcher Award recognizes distinguished scholars whose sustained scientific contributions, publication record, scholarly influence, and leadership have significantly advanced their respective disciplines. Laurence Klotz of the University of Toronto is internationally recognized for his extensive contributions to medicine, particularly in the field of urology and prostate cancer research. His scholarly productivity, citation impact, and leadership in clinical research demonstrate the qualities commonly associated with internationally recognized academic excellence.[1]
Abstract
Laurence Klotz has established an internationally respected academic profile through decades of clinical investigation, scholarly publication, and leadership within medicine. His research has focused extensively on prostate cancer diagnosis, management, active surveillance, and evidence-based clinical practice. A substantial publication portfolio and strong citation performance demonstrate the widespread influence of his scientific work across medical research communities.[1]
Keywords
Best Researcher Award, Laurence Klotz, University of Toronto, Medicine, Urology, Prostate Cancer, Clinical Research, Active Surveillance, Medical Innovation, Scientific Publications.
Introduction
Recognition through a Best Researcher Award generally reflects sustained scholarly productivity, innovation, research quality, international visibility, and measurable scientific impact. Laurence Klotz has contributed extensively to advancing evidence-based medicine through clinical investigations and peer-reviewed publications that have influenced patient management strategies and international clinical discussions.[2]
Research Profile
- Institution: University of Toronto
- Country: Canada
- Primary Discipline: Medicine
- Scopus Author ID: 55040556500
- Indexed Documents: 598
- Citation Count: 33,603
- h-index: 87
Research Contributions
The research contributions of Laurence Klotz encompass clinical trials, translational medicine, evidence-based treatment strategies, and innovations in prostate cancer management. His investigations have supported advances in active surveillance protocols, patient risk stratification, biomarker evaluation, and improvements in clinical decision-making. These studies have contributed to contemporary understanding of disease progression while supporting safer and more personalized treatment pathways.[2]
Publications
- Over 598 indexed scholarly publications in Scopus.
- Research published in internationally recognized peer-reviewed medical journals.
- Representative publication includes research related to active surveillance for prostate cancer.
Research Impact
A citation count exceeding thirty-three thousand together with an h-index of eighty-seven reflects broad scholarly recognition and sustained influence within the medical research community. Such bibliometric indicators demonstrate that published findings have been consistently referenced by researchers, clinicians, and guideline developers internationally.[1]
Award Suitability
Based on publicly available scholarly metrics and research accomplishments, Laurence Klotz demonstrates many characteristics commonly considered during evaluations for international academic recognition programs. These include sustained publication productivity, high citation impact, influential clinical research, interdisciplinary collaboration, scientific leadership, and measurable contributions to medical knowledge. Award decisions remain dependent upon the formal evaluation criteria established by the organizing committee of the International Popular Scientist Awards.[3]
Conclusion
Laurence Klotz has developed a distinguished international academic profile characterized by extensive publication activity, strong citation performance, and influential contributions to medicine. His research achievements, leadership within clinical science, and continued scholarly engagement illustrate the qualities frequently associated with internationally recognized research excellence and provide an informative example of academic achievement within the context of the Best Researcher Award.
External Links
References
- Elsevier. (n.d.). Scopus author details: Laurence Klotz, Author ID 55040556500. Scopus.
https://www.scopus.com/pages/authors/55040556500
- Klotz, L. (2010). Active surveillance for favorable-risk prostate cancer. Journal of Clinical Oncology.
DOI: https://doi.org/10.1200/JCO.2010.31.6951
- International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
https://popularscientist.com/
- Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Gnanapragasam, V. J., Klotz, L., Taneja, S. S., George, A. K., Catalona, W. J., Hadaschik, B. A., Marks, L. S., … Emberton, M. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis.